Operose Advisors’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Operose Advisors’s Portfolio BSTZ Stock Details BSTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.11K	Buy	+303	New	+$8.37K	﹤0.01%	416

Other funds holding BSTZ

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Operose Advisors's BSTZ Position: Q2 2026 in Review

Operose Advisors opened a new position in BlackRock Science and Technology Term Trust (BSTZ) in Q2 2026: 303 shares worth $9.11K. The stake represents ﹤0.01% of the portfolio and ranks #416 among its holdings.

152 funds tracked by Wall St. Rank hold BSTZ as of Q2 2026.

Operose Advisors held 303 shares of BlackRock Science and Technology Term Trust worth $9.11K as of Q2 2026.
BlackRock Science and Technology Term Trust was a new Operose Advisors position in Q2 2026.
BlackRock Science and Technology Term Trust made up ﹤0.01% of Operose Advisors's portfolio in Q2 2026, its #416 holding.
152 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.